Mapping Key Past and Current Debate on Areas beyond National Jurisdiction

The history of the law of the sea is part and parcel of a wider vision for the law of nation’s connection with globalization

The Greening of Norwegian Fisheries Legislation

The objective of both international and national fisheries management legislation has traditionally been to optimize utilization of individual fish stocks. Recently the environmental effects of fishing, including overfishing, by-catches, and destruction of habitat, have come into focus. International instruments (binding and non-binding) have been adopted to accommodate these concerns through introducing environmental principles (e.g. the precautionary approach and ecosystem approach) to supplement international fisheries law and international environmental law. In 2009 new legislation came into force in Norway to introduce these obligations. The legislation is investigated to assess how environmental considerations are implemented and weighted against other considerations, such as settlement and employment, traditionally important interests in fisheries management. The new legislation means fisheries management must apply objectives and principles across sectors to include utilization of all natural resources. The conclusion is that although the fisheries management agencies still enjoy wide discretion, the implementation of these principles and their integration with other sectors will require a more holistic approach to fisheries management in the future.Keywords: Implementation of international fisheries and international environmental law, Norwegian fisheries law, Norwegian environmental and natural resources law, Norwegian administrative law.Citation: Arctic Review on Law and Politics, vol. 1, 1/2010 p. 131–157. ISSN 1891-625

Conservation and Sustainable Use of Arctic Marine Biodiversity:

The status of the marine Arctic as ‘the last wilderness’ may be challenged in future by increased activities provided by the melting of the sea ice. The fragile ecosystems and habitats may come under threat. In this article the international law on conservation and sustainable use of marine biodiversity is explored where the ecosystem approach has been developed, and these legal and semi-legal norms are related to the marine Arctic. Particularly challenging is to implement the ecosystem approach within the maritime jurisdiction. Although still a wilderness, state practice indicates that implementation will not be any easier in the Arctic, and that it will not become a laboratory for new legal regimes. Most likely sectoral regulatory regimes will be extended or developed as different threats materialize. One of the main challenges will be to ensure proper coordination between these to apply the ecosystem approach.Keywords: Arctic, international environmental law, biodiversity, law of the seaCitation: Arctic Review on Law and Politics, vol. 1, 2/2010 p. 249-278. ISSN 1891-625

Avinor - Bodø lufthavn : fra terminalbedrift til flyplassdrift

Masteroppgave i bedriftsledelse (MBA) - Universitetet i Nordland, Bodø, 2013Sperra for utlån til 2019-01-3

Stewardship, Transformational Change, and Regime Shifts in the Arctic

(Published: November 2016)Citation: T. Henriksen and Ø. Ravna. ‘‘Stewardship, Transformational Change, and Regime Shifts in the Arctic.’’ Arctic Review on Law and Politics, Vol. 7, No. 2, 2016, pp. 109–110. http://dx.doi.org/10.17585/arctic.v7.58

Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus

Source at https://doi.org/10.1186/s12933-016-0492-4.Background: Gestational diabetes mellitus (GDM) is a significant risk factor for cardiovascular disease (CVD) in later life, but the mechanism remains unclear. Adipokine imbalance in the presence of metabolic dysfunction may be a key event in promoting CVD. The aim of the study was to examine the relationships between GDM, cardiovascular risk, and plasma adiponectin, leptin and the leptin/adiponectin (L/A) ratio in pregnancy and at 5 years after the index pregnancy. Methods: This population-based prospective cohort included 300 women who had an oral glucose tolerance test (OGTT) during pregnancy. Five years later, the OGTT was repeated along with dual-energy X-ray absorptiometry, lipid analysis, and pulse wave velocity analysis. Fasting adiponectin and leptin levels were measured four times during pregnancy and at follow-up. Results: We found the L/A ratio higher in GDM women during both pregnancy and follow-up compared to nonGDM women. A high L/A ratio during pregnancy was associated with CV risk based on lipid ratios at follow-up, especially the TG/HDL-C ratio. Further, interaction analysis indicated that an increase in the L/A ratio of 1 unit was associated with a higher CV risk in GDM compared to normal pregnancy. Finally, low adiponectin levels independently predicted increased lipid ratios at follow-up. Conclusions: Taken together, our findings suggest that high L/A ratio in pregnancy and in particularly in those with GDM are associated with an unfavorable CVD risk profile during follow-up. Future studies should investigate if a dysregulated leptin and adiponectin profile during pregnancy is associated with atherosclerotic disease during long-term follow-up

What determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjective health status of COPD patients

<p>Abstract</p> <p>Background</p> <p>Subjective health status is the result of an interaction between physiological and psychosocial factors in patients with chronic obstructive pulmonary disease (COPD). However, there is little understanding of multivariate explanations of subjective health status in COPD. The purpose of this study was to explore what determines subjective health status in COPD by evaluating the relationships between background variables such as age and sex, predicted FEV₁%, oxygen saturation, breathlessness, anxiety and depression, exercise capacity, and physical and mental health.</p> <p>Methods</p> <p>This study had a cross-sectional design, and included 100 COPD patients (51% men, mean age 66.1 years). Lung function was assessed by predicted FEV₁%, oxygen saturation by transcutaneous pulse oximeter, symptoms with the St George Respiratory Questionnaire and the Hospital Anxiety and Depression Scale, physical function with the Incremental Shuttle Walking Test, and subjective health status with the SF-36 health survey. Linear regression analysis was used.</p> <p>Results</p> <p>Older patients reported less breathlessness and women reported more anxiety (p < 0.050). Women, older patients, those with lower predicted FEV₁%, and those with greater depression had lower physical function (p < 0.050). Patients with higher predicted FEV₁%, those with more breathlessness, and those with more anxiety or depression reported lower subjective health status (p < 0.050). Symptoms explained the greatest variance in subjective health status (35%–51%).</p> <p>Conclusion</p> <p>Symptoms are more important for the subjective health status of patients with COPD than demographics, physiological variables, or physical function. These findings should be considered in the treatment and care of these patients.</p

Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial

Background: Hip fracture patients face a patient safety threat due to medication discrepancies and adverse drug reactions when they have a combination of high age, polypharmacy and several care transitions. Consequently, optimised pharmacotherapy through medication reviews and seamless communication of medication information between care settings is necessary. The primary aim of this study was to investigate the impact on medication management and pharmacotherapy. The secondary aim was to evaluate implementation of the novel Patient Pathway Pharmacist intervention for hip fracture patients. Methods: Hip fracture patients were included in this nonrandomised controlled trial, comparing a prospective intervention group (n = 58) with pre-intervention controls who received standard care (n = 50). The Patient Pathway Pharmacist intervention consisted of the steps: (A) medication reconciliation at admission to hospital, (B) medication review during hospitalisation, (C) recommendation for the medication information in the hospital discharge summary, (D) medication reconciliation at admission to rehabilitation, and (E) medication reconciliation and (F) review after hospital discharge. The primary outcome measure was quality score of the medication information in the discharge summary (range 0-14). Secondary outcomes were potentially inappropriate medications (PIMs) at discharge, proportion receiving pharmacotherapy according to guidelines (e.g. prophylactic laxatives and osteoporosis pharmacotherapy), and all-cause readmission and mortality. Results: The quality score of the discharge summaries was significantly higher for the intervention patients (12.3 vs. 7.2, p Conclusion: The intervention steps were successfully implemented for hip fracture patients and contributed to patient safety through a higher quality medication information in the discharge summary, fewer PIMs and optimised pharmacotherapy

Medication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records

Objective: Patients with hip fracture are at high risk of medication errors due to a combination of high age, comorbidities, polypharmacy and several care transitions after fracture. The aim was to study medication management tasks concerning patient safety: medication reconciliation, medication review and communication of key medication information in care transitions. Design: Descriptive study comprising a self-administered clinician survey (MedHipPro-Q) and a retrospective review of hospital medical records of patients with hip fracture. Setting: Regional hospital and the associated primary care units (South-Eastern Norway). Participants: The survey received responses from 253 clinicians, 61 medical doctors and 192 nurses, involved in the medication management of patients with hip fracture, from acute admittance to the regional hospital, through an in-hospital fast track, primary care rehabilitation and back to permanent residence. Respondents' representativeness was unknown, introducing a risk of selection and non-response bias, and extrapolating findings should be done with caution. The patient records review included a random sample of records of patients with hip fracture (n=50). Outcome measures: Medication reconciliation, medication review and communication of medication information from two perspectives: the clinicians' (ie, experiences with medication management) and the practice (ie, documentation of completed medication management). Results: In the survey, most clinicians stated they performed medication reconciliation (79%) and experienced that patients often arrived without a medication list after care transition (37%). Doctors agreed that more patients would benefit from medication reviews (86%). In the hospital patient records, completed medication reconciliation was documented in most patients (76%). Medication review was documented in 2 of 50 patients (4%). Discharge summary guidelines were followed fully for 3 of 50 patients (6%). Conclusion: Our study revealed a need for improved medication management for patients with hip fracture. Patients were at risk of medication information not being transferred correctly between care settings, and medication reviews seemed to be underused in clinical practice